Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nektar Therapeutics
13G/A
Amendment 2
NKTR · 640268306
|
9.8% |
9/28/2026
Event 9/25/2026
|
|||
| Two Seas Capital LP | 9.8% | ||||
| Two Seas Capital GP LLC | 9.8% | ||||
| Sina Toussi | 9.8% | ||||
|
Sable Offshore Corp.
13G
SOC · 78574H104
|
5.4% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 5.4% | ||||
| Two Seas Capital GP LLC | 5.4% | ||||
| Sina Toussi | 5.4% | ||||
|
Calumet, Inc.
13G/A
Amendment 3
CLMT · 131428104
|
7.5% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 7.5% | ||||
| Two Seas Capital GP LLC | 7.5% | ||||
| Sina Toussi | 7.5% | ||||
|
Quantum Corporation
13G
QMCO · 747906600
|
6.3% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 6.3% | ||||
| Two Seas Capital GP LLC | 6.3% | ||||
| Sina Toussi | 6.3% | ||||
|
Nektar Therapeutics
13G/A
Amendment 1
NKTR · 640268306
|
9.1% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 9.1% | ||||
| Two Seas Capital GP LLC | 9.1% | ||||
| Sina Toussi | 9.1% | ||||
|
PAVmed Inc.
13G
PAVM · 70387R502
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Veradigm Inc.
13G/A
Amendment 2
MDRX · 01988P108
|
8.2% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 8.2% | ||||
| Two Seas Capital GP LLC | 8.2% | ||||
| Sina Toussi | 8.2% | ||||
|
Arbutus Biopharma Corporation
13G/A
Amendment 2
ABUS · 03879J100
|
9.4% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 9.4% | ||||
| Two Seas Capital GP LLC | 9.4% | ||||
| Sina Toussi | 9.4% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 11
CORZ · 21874A106
|
4.4% |
4/23/2026
Event 4/23/2026
|
|||
| Two Seas Capital LP | 4.4% | ||||
| Two Seas Capital GP LLC | 4.4% | ||||
| Sina Toussi | 4.4% | ||||
|
Nektar Therapeutics
13G
NKTR · 640268306
|
6.8% |
4/17/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 6.8% | ||||
| Two Seas Capital GP LLC | 6.8% | ||||
| Sina Toussi | 6.8% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 10
CORZ · 21874A106
|
5.7% |
4/16/2026
Event 4/14/2026
|
|||
| Two Seas Capital LP | 5.7% | ||||
| Two Seas Capital GP LLC | 5.7% | ||||
| Sina Toussi | 5.7% | ||||
|
Odyssey Marine Exploration Inc
13D
OMEX · 676118201
|
10.0% |
4/13/2026
Event 4/8/2026
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 9
CORZ · 21874A106
|
5.5% |
3/20/2026
Event 3/18/2026
|
|||
| Two Seas Capital LP | 5.5% | ||||
| Two Seas Capital GP LLC | 5.5% | ||||
| Sina Toussi | 5.5% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 8
CORZ · 21874A106
|
5.9% |
3/4/2026
Event 3/2/2026
|
|||
| Two Seas Capital LP | 5.9% | ||||
| Two Seas Capital GP LLC | 5.9% | ||||
| Sina Toussi | 5.9% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 7
CORZ · 21874A106
|
6.7% |
2/19/2026
Event 2/18/2026
|
|||
| Two Seas Capital LP | 6.7% | ||||
| Two Seas Capital GP LLC | 6.7% | ||||
| Sina Toussi | 6.7% | ||||
|
Avadel Pharmaceuticals PLC
13G/A
Amendment 2
AVDL · G29687103
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Two Seas Capital LP | 0% | ||||
| Two Seas Capital GP LLC | 0% | ||||
| Sina Toussi | 0% | ||||
|
Calumet, Inc.
13G/A
Amendment 2
CLMT · 131428104
|
9.3% |
2/17/2026
Event 12/31/2025
|
|||
| Two Seas Capital LP | 9.3% | ||||
| Two Seas Capital GP LLC | 9.3% | ||||
| Sina Toussi | 9.3% | ||||
|
Veradigm Inc.
13G/A
Amendment 1
MDRX · 01988P108
|
6.9% |
2/17/2026
Event 12/31/2025
|
|||
| Two Seas Capital LP | 6.9% | ||||
| Two Seas Capital GP LLC | 6.9% | ||||
| Sina Toussi | 6.9% | ||||
|
Arbutus Biopharma Corp
13G/A
Amendment 1
ABUS · 03879J100
|
6.5% |
2/17/2026
Event 12/31/2025
|
|||
| Two Seas Capital LP | 6.5% | ||||
| Two Seas Capital GP LLC | 6.5% | ||||
| Sina Toussi | 6.5% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 6
CORZ · 21874A106
|
7.2% |
1/20/2026
Event 1/15/2026
|
|||
| Two Seas Capital LP | 7.2% | ||||
| Two Seas Capital GP LLC | 7.2% | ||||
| Sina Toussi | 7.2% | ||||
|
Indivior PLC
13D/A
Amendment 13
INDV · G4766E116
|
4.98% |
12/23/2025
Event 12/23/2025
|
|||
| Two Seas Capital LP | 4.98% | ||||
| Two Seas Capital GP LLC | 4.98% | ||||
| Sina Toussi | 4.98% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 5
CORZ · 21874A106
|
8.1% |
12/18/2025
Event 12/16/2025
|
|||
| Two Seas Capital LP | 8.1% | ||||
| Two Seas Capital GP LLC | 8.1% | ||||
| Sina Toussi | 8.1% | ||||
|
Indivior PLC
13D/A
Amendment 12
INDV · G4766E116
|
5.7% |
12/10/2025
Event 12/8/2025
|
|||
| Two Seas Capital LP | 5.7% | ||||
| Two Seas Capital GP LLC | 5.7% | ||||
| Sina Toussi | 5.7% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 4
CORZ · 21874A106
|
7.9% |
12/1/2025
Event 11/26/2025
|
|||
| Two Seas Capital LP | 7.9% | ||||
| Two Seas Capital GP LLC | 7.9% | ||||
| Sina Toussi | 7.9% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 3
CORZ · 21874A106
|
8.0% |
11/17/2025
Event 11/13/2025
|
|||
| Two Seas Capital LP | 8.0% | ||||
| Two Seas Capital GP LLC | 8.0% | ||||
| Sina Toussi | 8.0% | ||||
|
Odyssey Marine Exploration Inc
13G/A
Amendment 9
OMEX · 676118201
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Veradigm Inc.
13G
MDRX · 01988P108
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 5.3% | ||||
| Two Seas Capital GP LLC | 5.3% | ||||
| Sina Toussi | 5.3% | ||||
|
Esperion Therapeutics, Inc.
13G/A
Amendment 1
ESPR · 29664W105
|
4.7% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 4.7% | ||||
| Two Seas Capital GP LLC | 4.7% | ||||
| Sina Toussi | 4.7% | ||||
|
Adaptimmune Therapeutics PLC
13G/A
Amendment 3
ADAPY · 00653A107
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 0% | ||||
| Two Seas Capital GP LLC | 0% | ||||
| Sina Toussi | 0% | ||||
|
Calumet, Inc.
13G/A
Amendment 1
CLMT · 131428104
|
7.8% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 7.8% | ||||
| Two Seas Capital GP LLC | 7.8% | ||||
| Sina Toussi | 7.8% | ||||
|
Gannett Co., Inc.
13G/A
Amendment 1
TDAY · 36472T109
|
9.6% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 9.6% | ||||
| Two Seas Capital GP LLC | 9.6% | ||||
| Sina Toussi | 9.6% | ||||
|
Indivior PLC
13D/A
Amendment 11
INDV · G4766E116
|
7.4% |
11/5/2025
Event 11/3/2025
|
|||
| Two Seas Capital LP | 7.4% | ||||
| Two Seas Capital GP LLC | 7.4% | ||||
| Sina Toussi | 7.4% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 2
CORZ · 21874A106
|
5.9% |
10/31/2025
Event 10/29/2025
|
|||
| Two Seas Capital LP | 5.9% | ||||
| Two Seas Capital GP LLC | 5.9% | ||||
| Sina Toussi | 5.9% | ||||
|
Core Scientific, Inc.
13D/A
Amendment 1
CORZ · 21874A106
|
6.5% |
10/9/2025
Event 10/7/2025
|
|||
| Two Seas Capital LP | 6.5% | ||||
| Two Seas Capital GP LLC | 6.5% | ||||
| Sina Toussi | 6.5% | ||||
|
Indivior PLC
13D/A
Amendment 10
INDV · G4766E116
|
8.3% |
9/5/2025
Event 9/3/2025
|
|||
| Two Seas Capital LP | 8.3% | ||||
| Two Seas Capital GP LLC | 8.3% | ||||
| Sina Toussi | 8.3% | ||||
|
Esperion Therapeutics, Inc.
13G
ESPR · 29664W105
|
5.0% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 5.0% | ||||
| Two Seas Capital GP LLC | 5.0% | ||||
| Sina Toussi | 5.0% | ||||
|
Gannett Co., Inc.
13G
TDAY · 36472T109
|
7.7% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 7.7% | ||||
| Two Seas Capital GP LLC | 7.7% | ||||
| Sina Toussi | 7.7% | ||||
|
Calumet, Inc.
13G
CLMT · 131428104
|
5.2% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 5.2% | ||||
| Two Seas Capital GP LLC | 5.2% | ||||
| Sina Toussi | 5.2% | ||||
|
Adaptimmune Therapeutics PLC
13G/A
Amendment 2
ADAPY · 00653A107
|
8.5% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 8.5% | ||||
| Two Seas Capital GP LLC | 8.5% | ||||
| Sina Toussi | 8.5% | ||||
|
Avadel Pharmaceuticals plc
13G/A
Amendment 1
AVDL · G29687103
|
6.4% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 6.4% | ||||
| Two Seas Capital GP LLC | 6.4% | ||||
| Sina Toussi | 6.4% | ||||
|
Arbutus Biopharma Corporation
13G
ABUS · 03879J100
|
5.4% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 5.4% | ||||
| Two Seas Capital GP LLC | 5.4% | ||||
| Sina Toussi | 5.4% | ||||
|
Odyssey Marine Exploration, Inc.
13G/A
Amendment 8
OMEX · 676118201
|
9.5% |
8/13/2025
Event 6/30/2025
|
|||
| Two Seas Capital LP | 9.5% | ||||
| Two Seas Capital GP LLC | 9.5% | ||||
| Sina Toussi | 9.5% | ||||
|
Core Scientific, Inc./tx
13D
CORZ · 21874A106
|
6.3% |
8/8/2025
Event 8/7/2025
|
|||
| Two Seas Capital LP | 6.3% | ||||
| Two Seas Capital GP LLC | 6.3% | ||||
| Sina Toussi | 6.3% | ||||
|
Core Scientific, Inc.
13D
CORZ · 21874A106
|
6.3% |
8/8/2025
Event 8/7/2025
|
|||
| Two Seas Capital LP | 6.3% | ||||
| Two Seas Capital GP LLC | 6.3% | ||||
| Sina Toussi | 6.3% | ||||
|
Indivior PLC
13D/A
Amendment 9
INDV · G4766E116
|
9.3% |
7/29/2025
Event 7/25/2025
|
|||
| Two Seas Capital LP | 9.3% | ||||
| Two Seas Capital GP LLC | 9.3% | ||||
| Sina Toussi | 9.3% | ||||
|
Indivior PLC
13D/A
Amendment 8
INDV · G4766E116
|
9.7% |
7/14/2025
Event 7/10/2025
|
|||
| Two Seas Capital LP | 9.7% | ||||
| Two Seas Capital GP LLC | 9.7% | ||||
| Sina Toussi | 9.7% | ||||
|
Indivior PLC
13D/A
Amendment 7
INDV · G4766E116
|
9.7% |
6/18/2025
Event 6/17/2025
|
|||
| Two Seas Capital LP | 9.7% | ||||
| Two Seas Capital GP LLC | 9.7% | ||||
| Sina Toussi | 9.7% | ||||
|
Indivior PLC
13D/A
Amendment 6
INDV · G4766E116
|
9.5% |
5/22/2025
Event 5/20/2025
|
|||
| Two Seas Capital LP | 9.5% | ||||
| Two Seas Capital GP LLC | 9.5% | ||||
| Sina Toussi | 9.5% | ||||
|
Odyssey Marine Exploration, Inc.
13G/A
Amendment 7
OMEX · 676118201
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Adaptimmune Therapeutics PLC
13G/A
Amendment 1
ADAPY · 00653A107
|
8.0% |
5/15/2025
Event 3/31/2025
|
|||
| Two Seas Capital LP | 8.0% | ||||
| Two Seas Capital GP LLC | 8.0% | ||||
| Sina Toussi | 8.0% | ||||
|
Avadel Pharmaceuticals plc
13G
AVDL · G29687103
|
5.1% |
5/15/2025
Event 3/31/2025
|
|||
| Two Seas Capital LP | 5.1% | ||||
| Two Seas Capital GP LLC | 5.1% | ||||
| Sina Toussi | 5.1% | ||||
|
Indivior PLC
13D/A
Amendment 5
INDV · G4766E116
|
9.3% |
3/4/2025
Event 3/3/2025
|
|||
| Two Seas Capital LP | 9.3% | ||||
| Two Seas Capital GP LLC | 9.3% | ||||
| Sina Toussi | 9.3% | ||||
|
Odyssey Marine Exploration Inc
13G/A
Amendment 6
OMEX · 676118201
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Adaptimmune Therapeutics PLC
13G
ADAPY · 00653A107
|
5.8% |
2/14/2025
Event 12/31/2024
|
|||
| Two Seas Capital LP | 5.8% | ||||
| Two Seas Capital GP LLC | 5.8% | ||||
| Sina Toussi | 5.8% | ||||
|
Indivior PLC
13D/A
Amendment 4
INDV · G4766E116
|
9.6% |
1/17/2025
Event 1/15/2025
|
|||
| Two Seas Capital LP | 9.6% | ||||
| Two Seas Capital GP LLC | 9.6% | ||||
| Sina Toussi | 9.6% | ||||